108 related articles for article (PubMed ID: 27094049)
81. Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.
Scaringi S; Di Martino C; Zambonin D; Fazi M; Canonico G; Leo F; Ficari F; Tonelli F
World J Surg; 2013 Apr; 37(4):902-10. PubMed ID: 23381673
[TBL] [Abstract][Full Text] [Related]
82. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.
Matsuoka H; Ikeuchi H; Uchino M; Bando T; Takesue Y; Nishigami T; Tomita N
Int J Colorectal Dis; 2013 Jun; 28(6):829-34. PubMed ID: 23080343
[TBL] [Abstract][Full Text] [Related]
83. Malignancy in Crohn's disease: incidence and clinical characteristics in Japan.
Mizushima T; Ohno Y; Nakajima K; Kai Y; Iijima H; Sekimoto M; Nishida T; Nezu R; Ito T; Doki Y; Mori M
Digestion; 2010; 81(4):265-70. PubMed ID: 20134166
[TBL] [Abstract][Full Text] [Related]
84. Cicatrizing enteritis as a pathologic entity; analysis of 120 cases.
WARREN S; SOMMERS SC
Am J Pathol; 1948 May; 24(3):475-501. PubMed ID: 18859355
[No Abstract] [Full Text] [Related]
85. Fistula-associated anal adenocarcinoma: good results with aggressive therapy.
Gaertner WB; Hagerman GF; Finne CO; Alavi K; Jessurun J; Rothenberger DA; Madoff RD
Dis Colon Rectum; 2008 Jul; 51(7):1061-7. PubMed ID: 18418652
[TBL] [Abstract][Full Text] [Related]
86. Study of colorectal cancer with Crohn's disease.
Higashi D; Futami K; Kawahara K; Kamitani T; Seki K; Naritomi K; Egawa Y; Hirano K; Tamura T; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kinugasa T
Anticancer Res; 2007; 27(6A):3771-4. PubMed ID: 17970041
[TBL] [Abstract][Full Text] [Related]
87. The risk of cancer in patients with Crohn's disease.
von Roon AC; Reese G; Teare J; Constantinides V; Darzi AW; Tekkis PP
Dis Colon Rectum; 2007 Jun; 50(6):839-55. PubMed ID: 17308939
[TBL] [Abstract][Full Text] [Related]
88. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease.
Löffler M; Weckesser M; Franzius C; Schober O; Zimmer KP
Ann N Y Acad Sci; 2006 Aug; 1072():379-85. PubMed ID: 17057218
[TBL] [Abstract][Full Text] [Related]
89. Effects of radiotherapy on different histopathological types of rectal carcinoma.
Sengul N; Wexner SD; Woodhouse S; Arrigain S; Xu M; Larach JA; Ahn BK; Weiss EG; Nogueras JJ; Berho M
Colorectal Dis; 2006 May; 8(4):283-8. PubMed ID: 16630231
[TBL] [Abstract][Full Text] [Related]
90. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.
Jess T; Gamborg M; Matzen P; Munkholm P; Sørensen TI
Am J Gastroenterol; 2005 Dec; 100(12):2724-9. PubMed ID: 16393226
[TBL] [Abstract][Full Text] [Related]
91. Positron emission tomography in the investigation of pediatric inflammatory bowel disease.
Lemberg DA; Issenman RM; Cawdron R; Green T; Mernagh J; Skehan SJ; Nahmias C; Jacobson K
Inflamm Bowel Dis; 2005 Aug; 11(8):733-8. PubMed ID: 16043988
[TBL] [Abstract][Full Text] [Related]
92. Development of adenocarcinoma in chronic fistula in Crohn's disease.
Laurent S; Barbeaux A; Detroz B; Detry O; Louis E; Belaiche J; Meurisse M
Acta Gastroenterol Belg; 2005; 68(1):98-100. PubMed ID: 15832595
[TBL] [Abstract][Full Text] [Related]
93. Anal and rectal cancer in Crohn's disease.
Sjödahl RI; Myrelid P; Söderholm JD
Colorectal Dis; 2003 Sep; 5(5):490-5. PubMed ID: 12925087
[TBL] [Abstract][Full Text] [Related]
94. Dysplasia and colorectal cancer in Crohn's disease.
Ullman TA
J Clin Gastroenterol; 2003; 36(5 Suppl):S75-8; discussion S94-6. PubMed ID: 12702970
[No Abstract] [Full Text] [Related]
95. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies.
Neurath MF; Vehling D; Schunk K; Holtmann M; Brockmann H; Helisch A; Orth T; Schreckenberger M; Galle PR; Bartenstein P
Am J Gastroenterol; 2002 Aug; 97(8):1978-85. PubMed ID: 12190164
[TBL] [Abstract][Full Text] [Related]
96. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
97. Carcinoma arising in anorectal fistulas of Crohn's disease.
Ky A; Sohn N; Weinstein MA; Korelitz BI
Dis Colon Rectum; 1998 Aug; 41(8):992-6. PubMed ID: 9715154
[TBL] [Abstract][Full Text] [Related]
98. Lower gastrointestinal malignancy in Crohn's disease.
Connell WR; Sheffield JP; Kamm MA; Ritchie JK; Hawley PR; Lennard-Jones JE
Gut; 1994 Mar; 35(3):347-52. PubMed ID: 8150345
[TBL] [Abstract][Full Text] [Related]
99. Gastrointestinal malignancies in Crohn's disease. A 20-year experience.
Savoca PE; Ballantyne GH; Cahow CE
Dis Colon Rectum; 1990 Jan; 33(1):7-11. PubMed ID: 2295280
[TBL] [Abstract][Full Text] [Related]
100. Clinicopathological characteristics of cancer associated with Crohn's disease.
Sasaki H; Ikeuchi H; Bando T; Hirose K; Hirata A; Chohno T; Horio Y; Tomita N; Hirota S; Ide Y; Tsuchida Y; Uchino M
Surg Today; 2017 Jan; 47(1):35-41. PubMed ID: 27094049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
